Bayerische Motoren Werke ADR (BMWYY)
29.20
+0.00 (0.00%)
OP · Last Trade: Oct 29th, 2:34 PM EDT
Detailed Quote
| Previous Close | 29.20 |
|---|---|
| Open | - |
| Bid | - |
| Ask | - |
| Day's Range | N/A - N/A |
| 52 Week Range | N/A - N/A |
| Volume | 0 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
News & Press Releases
The European Union's ambitious semiconductor strategy, driven by the EU Chips Act, is gaining significant momentum, aiming to double the continent's global market share in chips to 20% by 2030. A cornerstone of this strategic push is the substantial €1.1 billion investment by GlobalFoundries (NASDAQ: GFS) to expand its manufacturing capabilities in Dresden, Germany. This [...]
Via TokenRing AI · October 28, 2025
BioMedNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) CEO Highlights Blockchain Home-Equity Platform Launch in Exclusive Benzinga Interview
Beeline Holdings (NASDAQ: BLNE) CEO and Co-Founder Nick Liuzza discussed the company’s growth trajectory and industry outlook in an exclusive interview with Benzinga, following the launch of BeelineEquity, the nation’s first blockchain-powered home-equity platform. The platform enables homeowners—particularly baby boomers seeking liquidity—to sell fractional equity in their properties without taking on debt or monthly payments, with each transaction tokenized on blockchain. Liuzza told Benzinga that Beeline closed five equity transactions last week, expects about 25 more within 45 days, and is already taking 2026 applications amid strong demand. He said the company plans to scale nationwide as anticipated interest rate cuts improve housing affordability and create powerful tailwinds for the digital mortgage sector.
Via Investor Brand Network · October 28, 2025
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Receives FDA Meeting Feedback Advancing AVERSA(TM) Fentanyl Toward 505(b)(2) NDA Submission
Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, today announced it has received final meeting minutes from its Sept. 18, 2025, virtual meeting with the U.S. Food and Drug Administration (FDA) regarding its lead product, AVERSA(TM) FENTANYL, an abuse-deterrent fentanyl transdermal system. The meeting with the Division of Anesthesiology, Addiction Medicine, and Pain Medicine confirmed the regulatory pathway as a 505(b)(2) New Drug Application and provided guidance on the reference listed drug and bridging strategy. The FDA also offered feedback on manufacturing validation, product specifications, and stability testing, along with expectations for in vitro manipulation and extraction studies to characterize AVERSA’s abuse-deterrent properties for potential NDA submission.
Via Investor Brand Network · October 28, 2025
What Patients Need to Know About the Remission Rate of Glioblastomas
Patients are overwhelmed when they are diagnosed with glioblastoma, the most deadly primary brain cancer. It resists existing treatments and recurs in all patients, with a relatively short survival time averaging 14-18 months. Understanding the rate of remission for this disease can therefore enable patients and their caregivers to have a clear picture of what to expect, and therefore be guided in making any decisions they need to make. We discuss some of the factors influencing remission in GBM.
Via Investor Brand Network · October 28, 2025
Soligenix Inc. (NASDAQ: SNGX) Research Highlights Breakthrough in High-Temperature Vaccine Stability
Current vaccines for Ebola and similar filoviruses face a major deployment barrier: Most require storage between 2°C and 8°C throughout transport, making them vulnerable to spoilage when exposed to the high ambient heat common in many outbreak regions ( https://ibn.fm/MZWfk ). Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company specializing in biodefense and rare disease vaccines, has published a peer-reviewed summary of new scientific data demonstrating long-term high-temperature stability of its protein subunit vaccine platform designed for Ebola and Marburg-related viruses ( https://ibn.fm/F2JpN ).
Via Investor Brand Network · October 28, 2025
October 25, 2025 -- Urtopia launches four new carbon fiber e-bikes this Black Friday, expanding its lineup to 11 models for every rider.
Via 24-7 Press Release · October 25, 2025
The global automotive industry is once again grappling with the specter of severe production disruptions, this time stemming from an escalating geopolitical dispute centered on Nexperia, a critical semiconductor supplier. Leading automotive parts manufacturer Robert Bosch GmbH is already preparing for potential furloughs and production adjustments, a stark indicator of the immediate and profound impact. [...]
Via TokenRing AI · October 24, 2025
New LED Therapy Kills Cancer Cells While Sparing Healthy Tissues
Many existing cancer treatments, such as chemotherapy and radiation, don’t distinguish between cancer cells and healthy body cells, and the healthy cells killed alongside cancer cells result in harsh side effects. Researchers are constantly looking for new treatments that are better able to target cancer cells while leaving healthy cells untouched. A new study seems to have uncovered a therapy that could do just that .
Via Investor Brand Network · October 24, 2025
Shares of automotive retailer Lithia Motors (NYSE:LAD)
jumped 5.1% in the afternoon session after the company reported record third-quarter revenue and a significant increase in earnings per share.
Via StockStory · October 23, 2025
Rolle, Switzerland – October 23, 2025 – Garrett Motion Inc. (NASDAQ: GTX), a global leader in turbocharging and automotive technologies, has seen its stock price surge to a new 52-week high today following the announcement of stronger-than-expected financial results for the third quarter of 2025. The company's robust performance, which significantly surpassed
Via MarketMinute · October 23, 2025
Tesla (NASDAQ: TSLA) has sent ripples of concern through the financial markets after reporting what analysts widely deemed a "disappointing" third-quarter 2025 earnings report. Despite achieving record revenue and vehicle deliveries, the electric vehicle giant saw a significant contraction in its net profit and operating margins, failing to meet ambitious
Via MarketMinute · October 23, 2025
New Study Provides Insights on the Cost of Treating Firearm Injuries in America
A study whose findings were recently published has provided insights into the cost of treating injuries resulting from firearms, with a key finding being that Medicaid was billed for a little more than half of the total amount of money spent on these injuries during the period covered by the study.
Via Investor Brand Network · October 23, 2025
Amsterdam, The Netherlands – October 22, 2025 – A deepening geopolitical standoff over Nexperia, a critical Dutch-headquartered semiconductor manufacturer, is sending shockwaves through the global automotive industry, threatening imminent production halts across Europe and beyond. The dispute, stemming from the Dutch government's unprecedented intervention into the Chinese-owned chipmaker and Beijing's swift retaliation, has laid bare [...]
Via TokenRing AI · October 22, 2025
Volkswagen (XTRA: VOW) has once again sounded the alarm over potential production interruptions, citing renewed semiconductor supply chain challenges exacerbated by escalating geopolitical tensions. The German automotive giant's warning, issued in mid-to-late October 2025, underscores the enduring fragility of global manufacturing networks and the critical role semiconductors play in modern vehicles. This latest development, rooted [...]
Via TokenRing AI · October 22, 2025
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Breast Cancer Awareness Month by Addressing Gaps in Screening and Advancing the IzoView Breast CT Solution
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device firm leading imaging-based solutions for better diagnosis, screening, and treatment of breast cancer patients, is bringing the challenges of current screening systems and the unique potential of the IzoView Breast CT Imaging solutions as part of efforts to mark Breast Cancer Awareness Month ( ibn.fm/Hml57 ).
Via Investor Brand Network · October 22, 2025
The Street spotlights five emerging micro-cap innovators reshaping their respective industries—from blockchain finance and AI cybersecurity to advanced mineral exploration, digital advertising, and regenerative biotechnology. As market interest accelerates toward companies driving innovation with measurable traction, these five companies below are capturing attention through strategic developments, leadership milestones, and breakthrough technologies that position them at the forefront of their respective sectors.
Via AB Newswire · October 21, 2025
Specificity, Inc. (OTCQB: SPTY), a leading digital marketing and ad tech innovator, announced the appointment of Robert Fedder as Chief Executive Officer. Fedder brings over 30 years of international leadership across Europe, the U.S., Australia, and Asia, with a proven record in scaling technology ventures and driving operational excellence.
Via AB Newswire · October 21, 2025
Amsterdam, Netherlands – October 21, 2025 – A deepening geopolitical rift between the Netherlands and China over the critical chipmaker Nexperia has sent shockwaves through the global automotive supply chain and intensified international trade tensions. The Dutch government's unprecedented move to seize control of Nexperia, citing national economic security and severe governance shortcomings, has triggered [...]
Via TokenRing AI · October 21, 2025
Researchers Develop Nanoparticles That Could Combat Scarring, Inflammation in ARLD
In the U.S., liver disease claims the lives of at least 52,000 people annually. Globally, statistics suggest that 1.5 billion individuals are affected by liver disease. However, ARLD, or alcohol-related liver disease, hasn’t garnered traction within the scientific community, until now .
Via Investor Brand Network · October 21, 2025
Nanomedicine’s Next Leap: Why Particle Size Matters in Cancer Drug Delivery
Oncotelic Therapeutics Inc. (OTCQB: OTLC) is advancing precision nanomedicine with its proprietary Deciparticle(TM) platform, beginning human trials for Sapu003, a 20nm nanoparticle formulation of Everolimus (Afinitor(R)). This scientific briefing explores why particle size is critical to drug efficacy, how Oncotelic’s technology enhances tumor targeting, and how its rapid IND platform accelerates clinical development across multiple assets.
Via Investor Brand Network · October 21, 2025
Dubai, United Arab Emirates--(Newsfile Corp. - October 21, 2025) - OneClickDrive has released new insights from its marketplace data, revealing...
Via Newsfile · October 21, 2025
Bimmer Performance Center has officially moved into its new state-of-the-art facility at 5014 Departure Drive, Raleigh, bringing a higher level of care, comfort, and performance to BMW service in the Triangle.
Via AB Newswire · October 20, 2025
PLANT CITY, FL - October 20, 2025 - My Car Guy of Plant City, located at 1410 E Baker St, is celebrating two years of providing expert European auto repair and full-service care to the Plant City community. Known as the area’s only European vehicle specialist, the shop is now preparing to launch a new customer-focused website designed to further enhance the service experience.
Via Get News · October 20, 2025
Washington D.C., October 19, 2025 – The global financial markets are still reeling from the seismic shift in trade policy enacted by the United States in April 2025. A comprehensive package of new trade tariffs, spearheaded by the administration, has fundamentally challenged decades of global economic integration, ushering in an
Via MarketMinute · October 19, 2025
These businesses are poised to grow over the long term.
Via The Motley Fool · October 19, 2025